Condition: Ovarian Cancer Stage III · Ovarian Cancer Stage IV · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
PREDAtOOR is a pilot study and this study aims at improving the selection of the best treatment strategy for patients with advanced ovarian cancer by using Camera Vision (CV) to predict outcomes of cyto reduction at the time of Diagnostic laparoscopy.
This description comes directly from the study's public registry record.
Liat Hogen, MD · 416-946-4501 · liat.hogen@uhn.ca
Ferdous Parveen, MBBS · 416-946-4501 · ferdous.parveen@uhn.ca
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Ginecologia Oncologica | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06017557